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ABSTRACT
We have sequenced the genome of the emerging
human pathogen Babesia microti and compared it
with that of other protozoa. B. microti has the
smallest nuclear genome among all Apicomplexan
parasites sequenced to date with three chromo-
somes encoding 3500 polypeptides, several of
which are species specific. Genome-wide phylogen-
etic analyses indicate that B. microti is significantly
distant from all species of Babesidae and Theileridae
and defines a new clade in the phylum Apicomplexa.
Furthermore, unlike all other Apicomplexa, its
mitochondrial genome is circular. Genome-scale
reconstruction of functional networks revealed that
B. microti has the minimal metabolic requirement for
intraerythrocytic protozoan parasitism. B. microti
multigene families differ from those of other
protozoa in both the copy number and organization.
Two lateral transfer events with significant metabolic
implications occurred during the evolution of this
parasite. The genomic sequencing of B. microti
identified several targets suitable for the develop-
ment of diagnostic assays and novel therapies for
human babesiosis.
INTRODUCTION
Babesia microti is the principal cause of human babesiosis
and one of the most common transfusion-transmitted
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pathogens in the United States (1–3). The parasite has a
worldwide distribution and has been cited as an emerging
health threat in the United States by the National Academy
of Sciences (4). B. microti is primarily transmitted to
humans by the tick vector, Ixodes scapularis, but also peri-
natally and through blood transfusion. The mortality rate
associated with human babesiosis is estimated to be between
3 and 28%. Most severe cases occur in people over the age
of 50 years or those who are asplenic, have cancer or HIV or
who are on an immunosuppressive therapy. The majority of
patients experience mild to moderate malaria-like
symptoms; however, in severe cases, the disease may be
associated with respiratory failure, multi-organ system dys-
function or coma (1–4). Both host and parasite factors con-
tribute to these symptoms, but the exact pathogenic
mechanisms remain unknown (5,6). No evidence of
extraerythrocytic cellular parasitism exists for B. microti.
Although the parasite has been classiﬁed as a member of
the Babesia genus, the accuracy of this classiﬁcation has
been debated for >50 years with some experts suggesting
that it belongs to the Theileria genus.
We describe here the ﬁrst sequence of the B. microti
genome from a patient isolate propagated in gerbils.
Sequence analysis revealed important information about
the genome organization, gene content and metabolic
capacities of this parasite and provides new insights into
its pathophysiology. Furthermore, the study identiﬁed
new targets for the development of diagnostic assays and
novel therapies for this important human pathogen.
Phylogenetic analysis using a large pool of coding se-
quences (CDS) strongly suggest that B. microti deﬁnes a
new taxonomic genus among Apicomplexa distinct from
Babesia and Theileria species.
MATERIALS AND METHODS
Strains and genome sequencing
The B. microti R1 isolate was obtained from an adult male
patient who experienced severe B. microti infection that
required hospital admission. Although the patient was
hospitalized in France, he lived in the United States in a
Babesia-endemic area. Prior to the onset of his illness, the
patient was in general good health, non-splenectomized
and with no other evidence of immune suppression.
Because the patient had fever, purpura, laboratory
evidence of hemolytic anemia and kidney failure,
B. microti infection was suspected and subsequently con-
ﬁrmed by blood smear, serology, rodent inoculation and
polymerase chain reaction (PCR) among other molecular
methods as outlined in the Results and Discussion section.
The patient was treated with clindamycin and quinine
after which he fully recovered.
The R1 and the Gray strain control were propagated
in immune-compromised gerbils or hamsters. B. microti
R1 DNA was extracted from agarose gel plugs and frag-
mented by mechanical shearing producing 3 and 10kb
inserts that were subsequently cloned into the pcDNA2.1
(www.invitrogen.com) and pCNS (pSU18 derived)
plasmids, respectively. In addition, a large insert (30 kb) bac-
terial artiﬁcial chromosome library was constructed by
cloning Sau3A partially digested genomic fragments into
the pBelo-BAC11 vector. Vector DNAs were puriﬁed and
end-sequenced using dye-terminator chemistry on ABI3730
sequencers. We collected 71 882, 59 193 and 3343 sequences,
respectively, from each DNA library. A ﬁrst assembly was
performed using Arachne (http://www.broadinstitute.org)
resulting in 522 contigs of >500nt (N50=38216) and
104 scaffolds of >2kbp (N50=951 194). We retained
only the clones containing contigs with >4 kb because the
B. microti R1 DNA was contaminated with Gerbil DNA.
The corresponding reads were assembled using the Phred/
Phrap/Consed software package (www.phrap.com) as
described by Vallenet et al. (7). We then obtained 139
contigs (N50=183364) with a cumulated size of
6 425 753bp. Three main scaffolds were determined and
attributed to the chromosomes. Contigs corresponding to
mitochondrial DNAs were identiﬁed by Basic Local
Alignment Search Tool (BLAST). Primer walks, PCRs
and in vitro transposition technology (Template
Generation System
TM
II Kit; Finnzyme, Espoo, Finland)
were used to obtain complete chromosome sequences. A
total of 10 328 sequences were used for gap closure and
quality assessment. Themitochondrial genome organization
was conﬁrmed by PCR and by sequencing full clone inserts.
PFGE analyses were performed in 0.5Tris-HCl, Borate,
EDTA (TBE) at 10C at 4V/cm using Gene Navigator
TM
(Pharmacia). 2D Pulsed Field Gel Electrophoresis (PFGE)
analyses were performed as previously described (8).
Genome annotation
Integration of resources using GAZE
The automatic gene prediction pipeline (Supplementary
Figure S1) was modiﬁed from a standard annotation
pipeline (9). Programs were used with default options fol-
lowing standard procedures. A semi-automatic procedure
was used to generate a ﬁrst training set of 690 gene models
from chromosome I sequence. A similar approach was
previously used to analyze the Encephalitozoon cuniculi
genome (10). To use these curated annotations in the
data integration step, transcript sequences of the genes
were mapped on the ﬁnal genomic assembly using
BLAST-like alignment tool (BLAT) (11), best match
(best BLAT score) per gene models were selected, and
each best match was realigned using Est2Genome (12) in
order to identify exon/intron boundaries. The mapping
was used to calibrate the ab initio SNAP (13) gene predic-
tion software and as an entry for GAZE (14). The same
approach was previously used with Apicomplexan EST
data. A collection of 426 440 public messenger RNAs
(mRNAs) from the clade of Apicomplexa (downloaded
from the EMBL database, release 98) were ﬁrst aligned
with the B. microti genome assembly using BLAT. To
reﬁne BLAT alignment, we used Est2Genome (12).
BLAT alignments were made using default parameters
between translated genomic and translated ESTs (11).
For protein sequences, the UniProt database (15) was
used to detect conserved proteins between B. microti and
other species. Apicomplexan proteins in the UniProt
database were ﬁrst aligned with the B. microti sequences
using BLAT (11), and alignments with a BLAT score over
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20 were selected. Subsequently, we extracted the genomic
regions where no protein hit had been found by BLAT
and then realigned the UniProt protein with more permis-
sive parameters. Alignments larger than 50 residues and
with >20 identity matches were selected. Each match was
then reﬁned using GeneWise (16) in order to identify exon/
intron boundaries.
Most of the genome comparisons were performed with
repeat-masked sequences. For this purpose, we searched
and sequentially masked several kinds of repeats including
(i) Apicomplexan-known repeats available in Repbase
(instead of the human data) using the RepeatMasker
program (17), (ii) tandem repeats using the TRF
program (18) and (iii) ab initio repeat detection using
RepeatScout (19). From this pipeline, 1.2% of the
assembled bases were masked. No further analysis of the
repeated sequences has been performed.
All the resources described here were used to automat-
ically build B. microti gene models using GAZE (14).
Individual predictions from each of the programs
(SNAP, GeneWise and Est2genome) were broken down
into segments (coding, intron and intergenic) and signals
(start codon, stop codon, splice acceptor, splice donor,
transcript start and transcript stop). Exons predicted
by SNAP, GeneWise and Est2genome were used as
coding segments. Introns predicted by GeneWise and
Est2genome were used as intron segments. Intergenic
segments were created from the span of each mRNA
with a negative score (to prevent genes splitting by
GAZE). Predicted repeats were used as intron and
intergenic segments in order to avoid prediction of genes
encoding proteins in such regions. A weight was assigned
to each resource. More importance was given to align-
ments than to ab initio predictions. Chromosome I
curated gene models were associated with stronger param-
eters to enable their consideration by GAZE. This weight
acts as a multiplier for the score of each information
source prior to processing by GAZE automaton. All
signals were given a ﬁxed score, but segment scores were
context sensitive: coding segment scores were linked to the
percentage identity (%ID) of the alignment, while intronic
segment scores were linked to the %ID of the ﬂanking
exons. Finally, gene predictions created by GAZE were
ﬁltered following their scores and lengths. When applied
to the entire assembled sequence, GAZE predicted 1426
gene models.
Annotation procedure
GlimmerHMM gene prediction software was used in
parallel with GAZE annotation. Parameters and training
were performed following published recommendations
(20). The training was performed on each chromosome
independently. GlimmerHMM predicts 3923 putative
CDS. The gene models have been curated according to a
semi-automatic procedure (Supplementary Figure S2).
BLASTX homology search (21) covering the whole
genome was performed as described by Katinka et al.
(10) and stored in an AceDB v4.9.38 database (http://
www.acedb.org/index.shtml). Artemis software (22) was
used as a graphic interface (Supplementary Figure S3).
Subtelomeric sequence organization
The miropeat v2.01 software (http://www.genome.ou.edu/
miropeats.html) and icatools v2.5 package (http://www.
littlest.co.uk/software/pub/bioinf/freeold) were compiled
on an Ubuntu Linux platform. The coordinates were
recovered from postscript output ﬁle. Ghostview was
used for the graphic representation of the miropeat
output (http://pages.cs.wisc.edu/ghost/). The genome
of B. microti was aligned to itself using BLASTN (21) to
conﬁrm and to reﬁne the structure of the
subtelomere-speciﬁc duplicated sequences (expect value
threshold at 0.0001).
Functional annotation
The functional annotation of the B. microti CDS was per-
formed by BLAST sequence comparison (21) against
UniProt and by searching for orthologues in deﬁned
species. Orthologous genes were identiﬁed using the bidir-
ectional best hit method (BBH). The analysis was per-
formed with three Apicomplexan parasites Plasmodium
falciparum, Babesia bovis and Theileria annulata as well
as with the yeast Saccharomyces cerevisiae and the
human pathogen Leishmania major. Homology searches
were performed at the protein level using BLASTP with
default options (21). Sequence data were obtained from
the Kyoto Encyclopedia of Genes and Genomes database
(KEGG) (23), PiroplasmDB and PlasmoDB (24). BBH
scores were collected in a relational database and
combined with the metabolic information provided by
KEGG (23) and the Malaria Parasite Metabolic
Pathway (MPMP, http://sites.huji.ac.il/malaria/) data-
bases (Supplementary Table S1).
The functional annotation was scored using different
parameters combining the results of different BBH
analyses. A ﬁrst score was given by the number of organ-
isms having orthologs for each B. microti CDS (parameter
o2[0,5]). The reliability of the annotation was also
assessed by the count of KEGG orthology group identiﬁ-
cation numbers (ko) associated with each ortholog (release
58.1, 1 June 2011). Two parameters were used in this case:
the number of KEGG ko number per B. microti CDS (k)
and the number of different ko (d). Three levels of anno-
tation were used, each associated with a different valid-
ation procedure (Supplementary Table S2): (i) the ko
number was directly inferred when o and k values were
high; (ii) for intermediate values of d and k, the annota-
tion was the only information stored (the protein was
declared as ‘valid’ and annotation was deduced from
BLAST best homologues’ description) and (iii) for low o
or k scores and also for high d values, we considered that
the annotation of a B. microti protein could not be
inferred from those of its orthologous sequences (‘No
Annotation’ denoted by ‘NA’).
Several metabolic charts of the KEGG and MPMP
databases were analyzed for this study. B. microti genes
encoding key enzymes and ‘missing’ genes in a given meta-
bolic pathway were further analyzed by gene-speciﬁc bio-
informatics approaches. Central metabolism has been
reconstructed by taking into account the carbon and
redox balance.
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Genome-wide phylogenetic analyses
Taxon sampling
The Apicomplexan phylogeny was analyzed based on a
taxon sampling including nine species representing differ-
ent families in the Apicomplexa phylum (25) and one
outgroup species, Tetrahymena thermophila. The annota-
tion of B. microti CDS (Supplementary Table S1) was
initiated to generate the complete set of data. Additional
sequences were directly obtained from KEGG (release
58.1, 1 June 2011).
Dataset assembly
To perform phylogenetic analyses, we assigned CDS of
B. microti to existing KEGG gene families (23). We
retained CDS having one orthologous sequence in each
tree of the three Apicomplexan parasites (described in
Supplementary Table S1) and associated with only one
KEGG ko identiﬁcation number (d=1). Using this
analysis, 1002 CDS were obtained. We ﬁltered those ko
families to retain only those containing one, and only one,
sequence for: (i) each of the eight Apicomplexan genomes
in the KEGG database, (ii) B. microti genome and (iii) T.
thermophila. This ﬁltration step reduced the B. microti
sequence set to 316 CDS. For each of the 316 orthology
groups, the sequences of these 10 organisms were collected
and aligned using MUSCLE v3.8.31 (26) (with default
options). Spurious alignment sites were then removed
using the ‘automated’ option of TrimAL v1.3 (27) that
establishes optimal thresholds based on the alignment
characteristics.
Tree inferences
Phylogenetic analyses were conducted on each of the 316
genes to infer the evolutionary history of each KEGG ko
family. The resulting trees were inferred by maximum like-
lihood, using RAxML v7.2.8 (28). Inferences were per-
formed starting from 10 distinct maximum parsimony
trees randomly chosen. The WAG protein model (29)
using empirical base frequencies and a discrete Gamma
law with four categories to model heterogeneity of evolu-
tionary rate among sites were chosen. Branch supports
were estimated through full bootstrap analyses, as
opposed to the faster RAxML bootstrap approximations.
Both supermatrix and supertree analyses were computed
using SeqCat.pl and SeqConverter.pl (http://www.
molekularesystematik.uni-oldenburg.de/33997.
html#Sequences) scripts to concatenate the 316 trimmed
alignments into a nexus ‘Supermatrix’ of 129 571 protein
sites. The Supermatrix was analyzed by RAxML, with the
same parameters mentioned above. To obtain the
supertree with the Matrix Representation with
Parsimony (MRP) method (30), a matrix for the 316
protein trees was computed with MRTOOLS (31),
weighting each clade of the protein trees according to its
bootstrap support. Accordingly, clades that may have
arisen from a low signal to noise ratio (low bootstrap)
had less inﬂuence on the inferred supertree than more
reliable clades (high bootstrap). The matrix was then
bootstrapped and analyzed with a parsimony criterion in
the PAUP* software (32). Supertree analysis was also
conducted by resorting to phySIC_IST (33), a more con-
servative supertree method that allows congruent study
among clades of individual gene histories with respect to
their bootstrap supports.
Supertree inferred by the PhySIC_IST method
The PhySIC_IST method (33) ﬁrst establishes a congru-
ence analysis of the gene trees and subsequently modiﬁes
these trees to remove pieces of topological signal in each
gene tree that conﬂict with the majority of other gene
trees. The 316 gene trees were curated by discarding
clades supported by a boostrap value below a threshold
were discarded, merging their two delimiting nodes in the
gene tree where they belong. Then for each triplet of taxa,
the frequencies of occurrence of the three possible
topologies for the triplet were compared on the basis of
the clades remaining after the bootstrap elimination step.
The P value of a 2 test was used to determine whether a
topology for a triplet observed in a gene tree was an
anomaly. In our study, a threshold value (STC=1-p)
was used to eliminate abnormal triplet topologies.
STC=1 means that no triplet topology will be rejected,
even if it appears in one gene tree and is in contradiction
with all other gene trees. The usual values are STC=0.95
or STC=0.8. Then clades of each gene tree inducing
rejected triplets were eliminated. Once the gene trees
were curated with this procedure, a deduced supertree in
total agreement with the modiﬁed gene trees was obtained.
More information on this method is available on http://
www.atgc-montpellier.fr/physic_ist/.
RESULTS AND DISCUSSION
B. microti genome sequence and analysis
Using a whole-genome shotgun strategy approach, we
sequenced the DNA content of the B. microti isolate R1
that was puriﬁed from infected human blood. The parasite
was positively identiﬁed as a B. microti using light micros-
copy, serological tests, PCR analyses, rDNA sequencing
and PFGE-based caryotyping and chromosomal restric-
tion proﬁling (Figure 1). The karyotype of the R1 strain
was similar to that of the standard laboratory Gray strain.
NotI restriction digestion revealed small differences on
chromosomes I and II between the two isolates (Figure
1D). An approximate 140 Gbp of raw sequence data
were generated using conventional Sanger sequencing
technologies. Three nuclear, one mitochondrial and one
apicoplast chromosomes comprise the DNA material of
the parasite. The overall size of the B. microti nuclear
genome is 6.5 Mbp, which is 20% smaller than that of
other piroplasms such as B. bovis and T. annulata and
72% smaller than that of the human malaria parasite P.
falciparum, thus making it the smallest Apicomplexan
genome ever sequenced (Table 1). This small size is most
likely the result of a regressive evolution from an ancestral
organism with a larger genome. The genome size and
structure of Apicomplexan parasites are as diverse as
their host range and life-style. Coccidian genomes are
between 60 and 80 Mbp and Plasmodium genomes are
between 20 and 25 Mbp. Interestingly, piroplasms have
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some of the smallest Apicomplexan genomes (Table 1).
The genome size and chromosome number of B. microti
are in the range of what has been described in other
piroplasms (34–36). B. microti belongs to the so-called
small Babesia and infects only the erythrocyte of its mam-
malian host (37) where it undergoes one or two divisions
prior to parasite egress and invasion by merozoites of new
red blood cells. The ability of the parasite to invade and
replicate in lymphocytes of the vertebrate host has been
suggested but was never conﬁrmed (38). Therefore, the
limited cellular host range of B. microti may account for
the dramatic reduction its genome size and structure.
More than 98% of the nuclear genome of B. microti has
been assembled and annotated. Approximately 3500 CDS
are present in the genome, making it the smallest set of
genes found in Apicomplexa. Comparison of the
B. microti genome with that of other piroplasms
revealed an unexpected diversity. Notably, B. bovis and
Theileria parva genomes contain 7% more genes and
T. annulata 16% more genes than B. microti (Table 1).
No synteny blocks encompassing more than ﬁve genes
could be found between B. microti and other
Apicomplexa. Between 60 and 80% of the additional
genes found in B. bovis and T. parva are members of
large multigenic families (e.g. vesa and SmORF or svsp
and Tpr, respectively). These families do not exist or
have not expanded in the B. microti genome. B. microti
contains only one large lineage-speciﬁc multigenic family
encoding the sero-reactive antigen BMN (39,40).
Twenty-four bmn genes are found in the B. microti
genome. The gene structure of B. microti is substantially
divergent from that of other Apicomplexa. The number of
introns is high with nearly 70% of B. microti genes inter-
rupted with short introns of 20–25 bp in length.
Functional annotation revealed that 60% of the pre-
dicted proteins of B. microti share homology with
proteins of known or putative functions and about half
of them have an assigned biological function in the
KEGG database (Supplementary Table S1).
Approximately 12% of the proteins with unknown
function are speciﬁc to B. microti. Two rDNA units are
found in tandem on chromosome III and 2 rRNA 5S
encoding genes and 44 tRNA genes are also present and
these are distributed throughout the three chromosomes.
The DNA sequence of B. microti has an average of 36%
G+C content. The G+C content is much lower at
chromosome ends. An A+T rich sequence of 1 kbp is
present in four copies in the genome: one on both chromo-
some I and II and two on chromosome III. This sequence
may function as a centromeric region (CEN,
Supplementary Figure S4). Analysis of the subtelomeric
regions revealed the presence of a small set of multigene
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Figure 1. Babesia microti strain R1 characterization. (A) Light-microscopy analysis of B. microti infected blood. Left: blood smear. Right: immuno-
ﬂuorescence analysis using serum from a hamster infected with the B. microti Gray standard laboratory strain. Similar serum was used for serological
assays. (B) PCR ampliﬁcation of the ssu gene using PIRO-A and PIRO-B primers (77). These primers amplify a 436 bp fragment in B. microti Gray
and R1 strains and a 408 bp fragment in B. divergens Rouen strain. The integrity of the PCR fragment was conﬁrmed by DNA sequencing. (C) B.
microti karyotype. PFGE conditions used are: left, 0.7% agarose, 400 s pulses for 55 h; right, 1% agarose, 200 s pulses for 65 h. Length polymorphism
between the R1 isolate and the Gray strain is observed on chromosome 1 and 2. (D) 2D-PFGE NotI Restriction Fragment Length Polymorphism
(RFLP) analysis of B. microti. Each chromosome length polymorphism results from a single RFLP of 15 kbp (see triangle and star for chromosome I
and II respectively). The genome structure of Gray and R1 strain may differ from each other only with a single recombination event. PFGE
conditions used are: 1.2 % agarose gel, pulse conditions, 5 s for 8 h, 15 s for 7 h and 30 s for 6 h, tension, 6.5V/cm.
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families associated with repeated blocks of sequences of
0.8–3 kbp (Figure 2). Some of these genes are members of
the B. microti sero-reactive antigen family (bmn) (39,40).
The presence of genes encoding surface antigens is a
common feature of many eukaryotic genomes and it
represent a important source of antigenic variation for
eukaryotic parasites (41,42). B. microti subtelomeric
regions contain pseudo-genes but also four copies of a
sequence homologous to members of the Theileria
speciﬁc Tpr multigenic family and three copies of a
sequence homologous to members of the B. bovis vesa
multigene family (Figure 2). Tpr- and vesa-like genes of
B. microti are divergent from those found in other
piroplasms and the presence of both multigene families
in the same genome is unique to B. microti. Interestingly,
whereas in Theileria the Tpr genes are not associated with
the telomeres and are dispersed throughout the chromo-
somes, in B. microti Tpr-like sequences are found near the
telomeres. Moreover, members of the bmn gene family are
present near the telomeres as well as in the coding core of
the chromosomes. Four of the B. microti repeated telo-
meric sequences are found in the middle of chromosome
III (IIIc cluster, Figure 2), suggesting that this chromo-
some likely derived from a fusion event between two an-
cestral chromosomes.
Unlike other Apicomplexa that have a linear mitochon-
drial genome, B. microti has a circular 11 kbp mitochon-
drial genome with two inverted repeats of 2.5 kbp
encompassing almost half of its size (Figure 3). The
genetic information carried in this genome is similar to
that found in other Apicomplexa and encodes three
proteins, cytb of the cytochrome bc complex (complex
III) and coxI and coxIII of the cytochrome c oxidase
(complex IV). The ribosomal lsu and ssu genes of
B. microti are fragmented. Their presence and organiza-
tion suggest a distinct evolution from that of other
Apicomplexa. The six ribosomal genes encoding lsu frag-
ments show an organization similar to that of previously
annotated mitochondrial genomes from other piroplasms
(43). Interestingly, unlike other species of the Babesia and
Theileria families that lack detectable ssu genes, two ribo-
somal genes encoding ssu fragments were found in the
B. microti mitochondrial genome.
B. microti defines a new Apicomplexan family
For many years, the classiﬁcation of B. microti as a
member of either the Babesia or Theileria families has
been controversial. Although many taxonomists have clas-
siﬁed B. microti as a member of the Babesia family, trans-
mission electron microscopy analyses and recent
molecular studies using two different genetic markers sug-
gested that this organism may be distinct from the other
species of this family (44–47). This limited set of molecular
markers was, however, insufﬁcient to ascertain the taxo-
nomic position of this parasite among Apicomplexa. To
address the evolution of B. microti among Apicomplexa, a
Table 1. Genomic features of B. microti and ﬁve other Apicomplexa
Feature B. microti B. bovis T. parva T. annulata P. falciparum C. parvum
Genome
Size (Mbp)a 6.5 8.2 8.3 8.4 23.3 9.1
Number of chromosomes 3 4 4 4 14 8
G+C content (%) 36 41.5 34.1 32.5 19.3 30.8
Genes
Number of genesb 3513 3706 3796 4082 5324 3805
Mean gene length (bp) 1327 1503 1407 1602 2326 1844
Mean gene length including introns (bp) 1471 1609 1654 1802 2590 1851
Gene density (bp per gene) 1816 2194 2059 2199 4374 2411
Coding regions (%) 73 68 68 73 53 76
Coding regions including introns (%) 81 73 80 82 59 77
Number of genes with introns (%) 70 60 75 71 54 4
Exons
Number per gene 3.3 2.8 2.7 3.9 2.6 1.1
Mean length (bp) 397 547 514 416 904 1748
Total length (%) 73 68 68 73 53 77
Introns
Number per gene 2.3 1.7 2.6 2.9 1.6 0.1
Number per gene presenting intron 3.4 2.9 3.5 4 2.9 1.3
Mean length (bp) 61 60 94 70 167 96
Total length (%) 8 5 12 9 6 0.02
Intergenic regions
Mean length (bp) 346 585 405 398 1784 561
Total length (%) 19 27 20 18 41 23
RNAs
Number of tRNA genesc 44 70 71 47 72 45
Number of 5S rRNA genes 2 ND 1 3 3 6
Number of 5.8S/18S/28S rRNA units 2 5 8 1 13 9
Quantitative data have been calculated using Artemis genome browser.
aEstimated size including gaps.
bData from Plasmodb 8.1 data for Apicomplexa. B. microti: this work.
cData from piroplasmoDB v1.1 and plasmoDB v8.1.
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set of 316 genes was selected from a total of 1002 CDS
that share signiﬁcant homology with CDS in the genomes
of B. bovis, T. annulata and P. falciparum. These 316 genes
belong to KEGG orthology groups and are present as
single copy genes in the B. microti genome as well as
that of eight Apicomplexan genomes selected for
genome-scale phylogenetic analysis. These include
B. bovis, T. annulata, T. parva, P. falciparum, Plasmodium
knowlesi, Plasmodium vivax, Toxoplasma gondii and
Cryptosporidium parvum. To locate the root of the phylo-
genetic tree, T. thermophila was used as an outgroup
species. Two independent phylogenetic analyses
produced in the same phylogenetic tree, placing
B. microti at the root of piroplasms and separating it
from the B. bovis and Theileria clades (Figure 4).
Approximately 88% of the selected proteins support the
evolutionary separation of B. microti from B. bovis and
Theileria species. The data indicate that Babesia is a para-
phyletic group, the taxonomy of which must be revised.
Furthermore, this analysis revealed that B. microti has
evolved early in the evolution of piroplasms. These
ﬁndings emphasize the need to create a new genus for
the B. microti group of strains.
Coding core
Chromosome
sequence extremity
Ia
vesa Tprbmn
Ib
IIa
vesa TM nmbnmb
IIb
IIIa
vesaBmn
Tpr nmbnmbnmb bmn
Bmn
IIIb
bmn Tpr bmn
bmnbmn
IIIc
bmn bmnbmn Tpr
0        1         2                  4   
kbp
S2
S3 S6
S4S1
S5
Unduplicated
S7
S8
Figure 2. Mosaic organization of the Babesia microti chromosome extremities. Chromosome ends are labeled according to Figure S2. These regions
are characterized by the presence of duplicated sequences scattered among the different chromosome extremities (S1–S8). Limits of sequence
homologies have been calculated using miropeat and BLASTN analyses. Annotated genes are indicated on the ﬁgure. Most repeated genes are
part of the bmn gene family and included truncated genes and pseudogenes. Several bmn genes are in transition regions between two duplicated
sequences. The S2 sequence encoding a putative VESA antigen is repeated three times. The S4 sequence encodes Tpr orthologues and is repeated four
times, two copies of which on chromosome ends IIb and IIIa are signiﬁcantly shorter. The GC content in the chromosome ends is signiﬁcantly lower
than in the coding core. The sequence between S1 and S4 at extremity Ib encodes a putative sugar transporter (TM). The sequence is not duplicated
but does not show any base composition bias compared to adjacent regions. It was not possible to precisely map the recombination sites associated
with the rearrangements that took place at chromosome ends (average resolution of 100 bp).
ls 5
lsu4
lsu6
lsu2
u
Babesia microti
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Figure 3. Circular organization of the Babesia microti mitochondrial
genome. IR: inverted repeats; cox1: cytochrome c oxidase subunit 1,
cox3: cytochrome c oxidase subunit 3, cytb: cytochrome bc complex
subunit. The numbering of the ribosomal lsu and ssu genes fragments
is performed according to the P. falciparum nomenclature.
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The minimal Apicomplexan metabolism of B. microti
Reconstruction of B. microti metabolism from its genomic
information suggests high dependence of the parasite on
glucose fermentation for energy production and redox
regulation (Figure 5). Genes encoding enzymes required
for b-oxidation and hemoglobin degradation were not
found in the genome of this organism. The analysis
further indicates that the parasite may not synthesize
heme or fatty acids de novo and lacks both mitochondrial
and apicoplast pyruvate dehydrogenases. Furthermore,
the function of the apicoplast seems to be limited to the
production of the precursors of isoprenoids through the
2-C-methyl-D-erythritol 4-phosphate/1-deoxy-D-xylulose
5-phosphate pathway (MEP/DOXP) pathway, a meta-
bolic function used by P. falciparum during its intraery-
throcytic development (48). A ferredoxin/ferrodoxin:
NAD oxidoreductase system is also present in the
apicoplast and may provide electrons to the MEP/
DOXP pathway resulting in the formation of isopentenyl
diphosphate (IPP) and dimethylallyl diphosphate
(DMAPP). Export of IPP and DMAPP to the cytosol
has been shown to be an essential step in the synthesis
of ubiquinones and dolichol and plays a critical role in
Plasmodium development (49). B. microti lacks a mito-
chondrial superoxide dismutase, suggesting a minimally
active respiratory chain. Consistent with this model, the
mitochondrial antioxidant system is underdeveloped. A
F0F1-ATPase made of a reduced number of subunits is
found in the genome, suggesting that oxidative phosphor-
ylation might take place in this organism. The gene
encoding frataxin, an enzyme involved in the assembly
of iron-sulfur clusters, was not identiﬁed in the genome,
indicating that it is either lacking or highly divergent from
known eukaryotic orthologs.
Another unique feature of B. microti central metabol-
ism is the acquisition of two genes by lateral gene
transfer: Bmldh encoding lactate dehydrogenase (LDH)
and Bmtpk encoding thiamine pyrophosphokinase
(TPK). Bmldh and Bmtpk genes lack introns and are
adjacent to each other on chromosome I but in
opposite orientation. This chromosomal site is at the
junction between the subtelomere and the coding
region, a genomic location known in many organisms
to be susceptible to double-stranded breaks and thus
suitable for insertion of foreign DNA. Reverse tran-
scriptase–PCR analyses show that Bmldh is transcribed
during the blood stage of the parasite, whereas the
Bmtpk is not (Supplementary Figure S5). In
Apicomplexa, LDH activity is believed to have
originated from a duplication of the LDH-like malate
dehydrogenase (mdh) gene (50–52). However, sequence
and phylogenetic analyses showed that the B. microti
LDH is not related to Apicomplexan LDH. Both the
protein and the gene share strong homology with their
mammalian counterparts, supporting a lateral gene
transfer mode of acquisition from the host
(Supplementary Figure S6A). Equally unique among
piroplasms, B. microti expresses a TPK protein
(BmTPK) with 70% identity to TPKs from Bartonella
species, which are transmitted by the same tick vector
that transmits B. microti. BmTPK shares very low
sequence similarity with TPKs from other eukaryotes
(Supplementary Figure S6B). Together, these ﬁndings
suggest that the Bmtpk gene may have been acquired
from bacteria by B. microti through lateral transfer, an
event that likely occurred during co-infection either in
the tick vector or in a mammalian host following a
tick bite. The presence of the Bmtpk gene in the
B. microti genome may enable the parasite to produce
thiamine pyrophosphate (ThiaPP), an essential cofactor
for key enzymes of the tricarboxylic acid (TCA) cycle.
The organization of the glycolytic machinery and TCA
cycle of piroplasm suggests a central role of the inner
membrane of the mitochondria in parasite metabolism
under anaerobic and microaerophilic conditions (53).
B. microti has several novel metabolic pathways consistent
with this model (Figure 5). In B. microti, no mdh gene
could be identiﬁed, suggesting that the malate:quinone
oxydoreductase (MQO) alone is responsible for the pro-
duction of malate. In the cytosol, the electron acceptor,
oxaloacetate may be obtained either from glycolysis or the
TCA cycle. A glycerol-3-phosphate (G3P)/dihydroxyacet-
one phosphate (DHAP) shuttle might provide electrons to
feed MQO for malate production. However, there is no
evidence that this electron transfer is fully responsible for
the regulation of the redox balance in the cell. It is likely
that B. microti produces pyruvate during its life cycle in
addition to lactate and malate.
Figure 4. Babesia microti deﬁnes a new clade in the Apicomplexan phylum. The tree is inferred using a maximum likelihood approach on a
concatenated alignment of 316 single-copy genes. Tetrahymena thermophila was included as outgroup. The same tree topology is inferred by a
supertree approach compiling the 316 trees inferred from the 316 genes. Labels indicate the boostrap support from both the Supermatrix and
Supertree analyses and the level of tree supporting the clade (%).
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Genome analysis has also revealed that B. microti
encodes a glutamine synthetase (GLS). The presence of
the GLS enzyme in B. microti is unique among piroplasms
and could provide the parasite with an alternative route
for nitrogen assimilation and ATP production. GLS and
glutamate dehydrogenase (GDH) enzymes are essential to
convert glutamine and glutamate into 2-oxoglutarate
(2OG) in order to feed the TCA cycle. Interestingly, the
GLS and GDH enzymes of B. microti lack a signal
peptide, suggesting that 2OG synthesis may take place in
the cytosol followed by subsequent transport into the
mitochondria where the TCA cycle might work in a re-
ductive way from 2OG to malate. Because of the absence
of TPK activity during intraerythrocytic development, the
acquisition of ThiaPP from the host might be critical to
equilibrate the redox balance of the mitochondria through
the activity of oxoglutarate dehydrogenase. Based on the
available genomic information, the oxidative TCA cycle of
B. microti appears to be similar to that of P. falciparum
(54). Complex III and IV of the respiratory chain are also
present in B. microti. The proton gradient might be used
by the F0F1-ATPase to produce ATP when the respiratory
chain is highly active.
Glycosylphosphatidylinositol biosynthesis and
glycosylphosphatidylinositol proteome
Glycosylphosphatidylinositol (GPI) anchors are glycoli-
pids attached to many cell surface glycoproteins of lower
and higher eukaryotes including important cell surface
parasite antigens (55–59). They have been shown to play
Figure 5. An integrated model for central metabolism of Babesia microti. Arrows show the direction of net ﬂuxes. Lactate and malate are expected
to be the major end products of the central metabolism. The gene encoding the lactate dehydrogenase is likely obtained by lateral transfer from a
mammalian host. The apicoplast is devoted to the production of isoprenoids precursors. Numbers in brackets represent the biochemical steps in the
reaction. Dashed arrows connect two reactions using the same metabolite. For simplicity, the membranes of the apicoplast and the outer membrane
of the mitochondrion is not shown. Abbreviation used are: (1) Metabolites: 1,3BPGA, 1,3-bisphosphoglycerate; 2OG, 2-oxoglutarate; Ace-R: acetate/
acetyl-CoA, c, cytochrome c; CoQ, Coenzyme-Q, ubiquinone; DHAP, dihydroxyacetone phosphate; e-, electrons; FBP, fructose 1,6-bisphosphate;
G3P, glycerol-3-phosphate; GAP, glyceraldehyde-3-phosphate; Glu, glutamate; Gln, glutamine; OAA, oxaloacetate, PEP, phosphoenolpyruvate.
(2) Enzymes (in red): ACS, AMP-forming acetyl-CoA synthetase; DHOD, dihydroorotate dehydrogenase; GLS, glutamine synthetase; GPDH,
glycerol-3-phosphate dehydrogenase (FAD- or NAD-dependent enzymes); LDH, lactate dehydrogenase; MQO, malate:quinone oxidoreductase;
NDH2, type II NADH:quinone oxidoreductase; OGDH, oxoglutarate dehydrogenase; PEPC, PEP carboxylase; PEPCK, PEP carboxykinase;
PDH, pyruvate dehydrogenase; PK, pyruvate kinase; SDH, succinate dehydrogenase; TH, transhydrogenase; III, complex III of the respiratory
chain; IV, complex IV of the respiratory chain; V, F0F1-ATP synthase.
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a critical function in the pathogenesis of Apicomplexan
parasites (60–62). GPI anchors are synthesized in a
stepwise manner in the membrane of the endoplasmic re-
ticulum and attached to the C-terminal end of proteins
following translation. The GPI biosynthetic pathways in
eukaryotes are highly conserved and produce a core struc-
ture of ethanolaminephosphate-6Mana1–2Mana1–
6Mana1–4GlcNa1–6-D-myoinositol-1-HPO4-lipid,
where the lipid is diacylglycerol, alkylacylglycerol or
ceramide. This minimal GPI structure may be embellished
with various side chain modiﬁcations such as additional
sugars or ethanolamine phosphate in a species-speciﬁc
manner. In addition to GPI, various intermediate mol-
ecules of the biosynthesis pathway are also accumulated
in the cytosol of parasites and some of them are secreted
and can induce inﬂammatory responses (63–65). Genes
encoding enzymes of the GPI biosynthetic pathway were
found in the B. microti genome indicating that the synthe-
sis of GPIs occurs in this organism (Supplementary Table
S3). The pagp1 deacylase was not found in the B. microti
genome, suggesting that GPI anchors made by this
parasite are likely to contain fully acylated inositol.
Unlike Plasmodium or Toxoplasma species, which
express three mannosyltransferases and harbor GPIs
with three mannose residues in their core structure (66),
the B. microti genome encodes only two mannosy-
ltransferases: PIGM and PIGV, and no homologues of
PIGB mannosyltransferase could be found. These
ﬁndings indicate that the core structure of the B. microti
GPI anchors may be different from that found in other
eukaryotes. The implications of such a unique GPI struc-
ture on host immune response and parasite evasion remain
to be determined.
Twelve putative GPI-anchored merozoite surface
protein-encoding genes have been identiﬁed in the
B. microti genome. All genes lack introns and their
encoded proteins have no homologs in other organisms,
including other Apicomplexa.
New insights into babesiosis therapy
Babesiosis therapy has generally been based on empirical
trials and medical consensus that combines antimalarial
drugs such as quinine or atovaquone with antibiotics
such as clindamycin or azithromycin (67–69). Treatment
failure due to suspected parasite drug resistance has been
reported (70). Genome analysis indicates that B. microti
lacks the proteases necessary to digest host hemoglobin.
This result along with the lack of hemozoin formation by
this parasite may explain the ineffectiveness of chloro-
quine in Babesiosis therapy and suggests that other com-
pounds of the aminoquinoline family are unlikely to be
effective. Conversely, because the B. microti genome
encodes a 1-deoxy-D-xylulose 5-phosphate reductoiso-
merase (Dxr) enzyme, the parasite may be sensitive to
the antibiotic fosmidomycin. Of the three major metabolic
pathways in the apicoplast, the DOXP pathway seems to
be the most conserved among Apicomplexa (71). Sequence
analyses revealed the presence of DOXP genes in several
Apicomplexa parasites including Babesia sp, Plasmodium,
T. gondii, Theileria and Neospora caninum. The encoded
Dxr proteins and their fosmidomycin binding sites are well
conserved (72–75). Studies in P. falciparum and Babesia
divergens have shown that both fosmidomycin and
FR900098 inhibit DOXR reductoisomerase and block
parasite proliferation (75). These compounds have no
effect on the growth of T. gondii or Theileria, even
though both parasites express Dxr enzymes, which
in vitro have been shown to be inhibited by Fosmidomycin
and FR900098. Cell biological analyses demonstrated that
the effectiveness of these drugs against Plasmodium and
Babesia species is largely due to the new permeation
pathways (NPP) induced by the parasites on the erythro-
cyte membrane (71,73). Although we do not yet know
whether B. microti induces NPP-like pathways on its
host plasma membrane and whether it expresses trans-
porters on the plasma and apicoplast membranes
capable of transporting these drugs, our metabolic recon-
struction analysis suggests that such transport mechan-
isms may exist in B. microti. Therefore, we predict that
both fosmidomycin and FR900098 are likely to inhibit
B. microti development and thus could be effective drug
candidates to treat human babesiosis. Fosmidomycin is
currently in phase two clinical trials for treatment of
uncomplicated malaria and has been shown to have an
excellent safety proﬁle in humans (75). Studies aimed to
assay the sensitivity of B. microti to fosmidomycin and
FR900098 in mice and hamsters are warranted and will
set the stage for the advancement of this class of com-
pounds for the treatment of human babesiosis. The
B. microti genome also encodes dihydropteroate
synthase and dihydrofolate reductase enzymes that are
the target of sulfadoxine and pyrimethamine, suggesting
that antifolates may be useful in the treatment of human
babesiosis (76).
In conclusion, sequencing of the B. microti genome
reveals new insights into the evolution of this parasite
and other Apicomplexan pathogens and opens new
avenues for future design of improved diagnostic assays
and antimicrobial drugs. Erythrocytes are the only cells
invaded by this parasite (37). Thus, the unique and rudi-
mentary metabolism of this human pathogen indicates that
the genome of B. microti contains the minimal genomic
requirement for successful intraerythrocytic parasitism.
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